Cancer Stem Cells Market Size & Share Analysis - Growth Trends And Forecasts (2024 - 2029)

Cancer Stem Cells Market Analysis

The Cancer Stem Cells Market size is estimated at USD 2.35 billion in 2024, and is expected to reach USD 4.09 billion by 2029, growing at a CAGR of 11.76% during the forecast period (2024-2029).

The increasing burden of cancer and fostering research and development (R&D) efforts by biopharmaceutical companies are projected to drive the cancer stem cell market. Moreover, increased focus on developing targeted therapies for cancer and fostering demand for personalized medicine has further accelerated the market's growth. For instance, in February 2022, the University of California, Irvine, established the Institute for Precision Health to deliver the most effective wellness strategy for individuals.

The institute focuses on precision health informatics and cancer stem cell therapeutics. Similarly, in June 2023, the National Cancer Institute (NCI) introduced the precision medicine initiative ComboMATCH for cancer patients. This approach involves knowledge of the patient’s tumor biology to decide the right combination of treatments for a patient. This information is critical in developing a regime that specifically targets cancer stem cells, thereby improving the treatment's outcome.

In recent years, stem cells have been used effectively in blood replenishment and immuno-reconstitution after cancer treatment. Also, these cells have gained remarkable traction across healthcare professionals for their role as a modality for delivering anti-tumor agents and their implication in tissue regeneration. A significant number of entities have reported positive outcomes of implementing this mode of tumor treatment. For instance, according to DVC Stem (Da Vinci Wellness Center) data published in October 2023, stem cells have shown promising outcomes in cancer, and approximately 87.5% of people reported improvement in their condition.

Similarly, in May 2023, a senior hematologist from Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, demonstrated the role of stem cells in the management of blood cancers and also emphasized their roles in successful treatments. Thus, the evolving landscape of stem cell therapies in cancer and the higher adoption of stem cell implants by healthcare professionals are likely to cater to the market's growth during the study period.

Moreover, the exponential rise in cancer cases facilitated the demand for advanced cancer therapeutics, including stem cell therapies. For instance, according to estimates from the National Cancer Institute of Brazil, around 704 thousand new cancer cases are expected to be diagnosed between 2023 and 2025, except non-melanoma skin cancer. The most diagnosed cancers in the country were prostate cancer, lung cancer, and breast cancer.

Thus, it has become very crucial to develop an efficient treatment to regulate cancer and improve the standard of living of cancer patients. Various public and private organizations are actively involved in the introduction of innovative solutions for the treatment of cancer. For instance, in October 2022, Bristol Myers Squibb (BMS) and Century Therapeutics formed a research collaboration to manufacture and commercialize four iPSC-derived (induced pluripotent stem cell) T-cell or natural killer cell programs for solid tumors and hematologic malignancies.

Furthermore, the growing research efforts and funding activities for stem cell research are expected to bolster the market's growth during the study period. For instance, in May 2024, the City of Hope received USD 5.4 million from the California Institute for Regenerative Medicine (CIRM) to build a stem cell research laboratory in the United States to expand research capabilities in cancer stem cell research. Such activities are further anticipated to foster the market's growth over the projected period.

Thus, the above-mentioned factors, such as the growing burden of cancer across the world and the growing efforts to develop targeted stem cell therapies for cancer, are anticipated to drive the market's growth.

However, factors such as the high cost of therapy and less penetration in low-and middle-income countries are anticipated to hamper the growth during the forecast period.

Cancer Stem Cells Market Trends

The Breast Cancer Segment is Expected to Hold a Major Share in the Market

Cancer Stem Cells Industry Segmentation

As per the scope of the report, cancer stem cells are a subpopulation of cancer cells characterized by their ability to self-renew and differentiate into various cell types, driving tumor growth and recurrence. Their unique properties contribute to treatment resistance and pose significant challenges in developing effective cancer therapies.

The cancer stem cells market is segmented by cancer type, application, and geography. Based on cancer type, the market is segmented as breast, blood, lung, brain, colorectal, pancreatic, bladder, liver, and other cancer types. Based on application, the market is segmented into targeted cancerous stem cells (CSCs) and stem cell-based cancer therapy. Based on geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

The report also covers the market sizes and forecasts for the cancer stem cells market in major countries across different regions. The market size is provided in terms of value (USD) for each segment.